231 related articles for article (PubMed ID: 22720842)
1. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study.
Goswami ND; Gadkowski LB; Piedrahita C; Bissette D; Ahearn MA; Blain ML; Østbye T; Saukkonen J; Stout JE
BMC Public Health; 2012 Jun; 12():468. PubMed ID: 22720842
[TBL] [Abstract][Full Text] [Related]
2. Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017.
Gonzalez-Reyes R; Katz D; Lambert L; Sorri Y; Narita M; Horne DJ;
PLoS One; 2024; 19(4):e0298628. PubMed ID: 38625902
[TBL] [Abstract][Full Text] [Related]
3. Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.
Spruijt I; Erkens C; Suurmond J; Huisman E; Koenders M; Kouw P; Toumanian S; Cobelens F; van den Hof S
PLoS One; 2019; 14(7):e0219252. PubMed ID: 31260502
[TBL] [Abstract][Full Text] [Related]
4. Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.
Woodruff R; Pratt R; Kolasa M
MMWR Surveill Summ; 2024 Jun; 73(4):1-18. PubMed ID: 38833409
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016.
Iqbal SA; Isenhour CJ; Mazurek G; Langer AJ; Chang MH; Truman BI
J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):E151-E161. PubMed ID: 31688742
[TBL] [Abstract][Full Text] [Related]
6. Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment.
Barss L; Obeng J; Fregonese F; Oxlade O; Adomako B; Afriyie AO; Frimpong ED; Winters N; Valiquette C; Menzies D
BMC Infect Dis; 2020 May; 20(1):352. PubMed ID: 32423422
[TBL] [Abstract][Full Text] [Related]
7. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
Rustage K; Lobe J; Hayward SE; Kristensen KL; Margineanu I; Stienstra Y; Goletti D; Zenner D; Noori T; Pareek M; Greenaway C; Friedland JS; Nellums LB; Hargreaves S;
Lancet Infect Dis; 2021 Dec; 21(12):1701-1712. PubMed ID: 34363771
[TBL] [Abstract][Full Text] [Related]
8. Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country.
Sullivan K; Pease C; Zwerling A; Mallick R; Van Dyk D; Mulpuru S; Allen C; Alsdurf H; Alvarez GG
BMC Public Health; 2021 May; 21(1):964. PubMed ID: 34020616
[TBL] [Abstract][Full Text] [Related]
9. Introduction of short course treatment for latent tuberculosis infection at a primary care facility for refugees in Winnipeg, Canada: A mixed methods evaluation.
Chevrier C; Diaz MH; Rueda ZV; Balakumar S; Haworth-Brockman M; Marin DM; Oliver A; Plourde P; Keynan Y
Front Public Health; 2022; 10():1064136. PubMed ID: 36726628
[TBL] [Abstract][Full Text] [Related]
10. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
11. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
12. Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis.
Séraphin MN; Hsu H; Chapman HJ; de Andrade Bezerra JL; Johnston L; Yang Y; Lauzardo M
BMC Public Health; 2019 Sep; 19(1):1214. PubMed ID: 31481046
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies.
Rebeiro PF; Cohen MJ; Ewing HM; Figueiredo MC; Peetluk LS; Andrade KB; Eakin M; Zechmeister EJ; Sterling TR
BMC Public Health; 2020 Jun; 20(1):897. PubMed ID: 32517671
[TBL] [Abstract][Full Text] [Related]
14. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
[TBL] [Abstract][Full Text] [Related]
15. Using Directly Observed Therapy (DOT) for latent tuberculosis treatment - A hit or a miss? A propensity score analysis of treatment completion among 274 homeless adults in Fulton County, GA.
Onwubiko U; Wall K; Sales RM; Holland DP
PLoS One; 2019; 14(6):e0218373. PubMed ID: 31226132
[TBL] [Abstract][Full Text] [Related]
16. Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study.
Page KR; Manabe YC; Adelakun A; Federline L; Cronin W; Campbell JD; Dorman SE
BMC Public Health; 2008 May; 8():158. PubMed ID: 18474110
[TBL] [Abstract][Full Text] [Related]
17. House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study.
Chang AH; Polesky A; Bhatia G
BMC Public Health; 2013 Sep; 13():894. PubMed ID: 24073620
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.
Sterling TR; Njie G; Zenner D; Cohn DL; Reves R; Ahmed A; Menzies D; Horsburgh CR; Crane CM; Burgos M; LoBue P; Winston CA; Belknap R
MMWR Recomm Rep; 2020 Feb; 69(1):1-11. PubMed ID: 32053584
[TBL] [Abstract][Full Text] [Related]
19. Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data.
Stockbridge EL; Miller TL; Carlson EK; Ho C
BMC Public Health; 2018 May; 18(1):662. PubMed ID: 29843664
[TBL] [Abstract][Full Text] [Related]
20. Latent tuberculous infection in the United States and Canada: who completes treatment and why?
Hirsch-Moverman Y; Shrestha-Kuwahara R; Bethel J; Blumberg HM; Venkatappa TK; Horsburgh CR; Colson PW;
Int J Tuberc Lung Dis; 2015 Jan; 19(1):31-8. PubMed ID: 25519787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
